Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Pfizer (PFE) Q1 Earnings & Sales Miss Estimates, Stock Down
02:42pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Pfizer (PFE) misses estimates for Q1 earnings and sales. It did not raise its sales guidance for 2022. Stock declines.
3 Growth Stocks to Buy With $1,000 Right Now
02:00pm, Tuesday, 03'rd May 2022 The Motley Fool
A small investment can go a long way.
IYH: Diversified Healthcare ETF Suitable For Short Term Investment
04:24am, Tuesday, 03'rd May 2022 Seeking Alpha
The IYH ETF has posted strong price returns over the medium and long term, but generated 1% yield. Read why I'll prefer to make IYH a trading instrument.
How Will Pfizer's (PFE) Key Drugs Perform in Q1 Earnings?
02:44pm, Monday, 02'nd May 2022 Zacks Investment Research
Higher sales of Pfizer's (PFE) key brands, Eliquis (alliance revenue), Xtandi and Inlyta, and revenues from the COVID-19 products are likely to have driven sales in the first quarter.
What 4 Analyst Ratings Have To Say About Bristol-Myers Squibb
01:44pm, Monday, 02'nd May 2022 Benzinga
Bristol-Myers Squibb (NYSE:BMY) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
1
2
1
0
Las
Bristol Myers Squibb (BMY) Q1 2022 Earnings Call Transcript
06:00pm, Friday, 29'th Apr 2022 The Motley Fool
BMY earnings call for the period ending March 31, 2022.
Bristol-Myers (BMY) Q1 Earnings Beat Estimates, Guidance Down
04:29pm, Friday, 29'th Apr 2022 Zacks Investment Research
Bristol-Myers (BMY) earnings beat estimates in the first quarter of 2022. Sales jump year over year on the back of Eliquis and new products.
Biopharma can perform well in recession based on past data, says Wells Fargo's Mohit Bansal
03:22pm, Friday, 29'th Apr 2022
Mohit Bansal, Wells Fargo Securities senior equity analyst, joins 'Power Lunch' to discuss biopharma and the market.
Core PCE Inflation at a 40-Year High in March
03:19pm, Friday, 29'th Apr 2022 Zacks Investment Research
Core PCE Inflation at a 40-Year High in March.
PCE +6.6%, Another 40-Year High; XOM, CL, BMY Report
02:40pm, Friday, 29'th Apr 2022 Zacks Investment Research
Inflation was clear and present in March, but a large chunk of it was due to food and energy prices.
'So bad, it's good.' This beleaguered stock market has one big asset on its side, say strategists.
01:49pm, Friday, 29'th Apr 2022 MarketWatch
It has been a rough April for investors, but there is still reason for cheer, says our call of the day.
Bristol-Myers (BMY) Q1 Earnings Beat Estimates, Guidance Down
01:33pm, Friday, 29'th Apr 2022
Bristol-Myers (BMY) earnings beat estimates in the first quarter of 2022. Sales jump year over year on the back of Eliquis and new products.
Core PCE Inflation at a 40-Year High in March
12:48pm, Friday, 29'th Apr 2022
Core PCE Inflation at a 40-Year High in March.
Bristol Myers Squibb (BMY) Q1 Earnings and Revenues Surpass Estimates
12:15pm, Friday, 29'th Apr 2022 Zacks Investment Research
Bristol Myers (BMY) delivered earnings and revenue surprises of 2.08% and 3.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
PCE +6.6%, Another 40-Year High; XOM, CL, BMY Report
12:02pm, Friday, 29'th Apr 2022
Inflation was clear and present in March, but a large chunk of it was due to food and energy prices.
